Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Classificação em ações #107
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Preço da ação
$41.14
Última sincronização: 2026-09-21
Valor de mercado
$182.76B
Variação (1 dia)
-7.78%
Variação (1 ano)
-32.24%
País
DK
Negociar Novo Nordisk A/S (NOVO-B)

Categoria

Receita da Novo Nordisk A/S (NOVO-B)
Receita em Jun 2026 TTM: $52.30B
De acordo com os últimos relatórios financeiros da Novo Nordisk A/S, a receita atual da empresa (TTM) é $52.30B. Em 2024, a empresa obteve uma receita de $40.52B um aumento em relação a a receita do ano 2023, que foi de $34.39B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Novo Nordisk A/S de 2000 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $52.30B 12.04%
2025 $46.68B 15.22%
2024 $40.52B 17.82%
2023 $34.39B 35.02%
2022 $25.47B 18.29%
2021 $21.53B 3.33%
2020 $20.84B 13.79%
2019 $18.31B 6.63%
2018 $17.17B -4.59%
2017 $18.00B 13.46%
2016 $15.86B 0.88%
2015 $15.73B 8.89%
2014 $14.44B -6.28%
2013 $15.41B 11.69%
2012 $13.80B 19.42%
2011 $11.55B 6.01%
2010 $10.90B 10.52%
2009 $9.86B 15.53%
2008 $8.54B 3.65%
2007 $8.24B 20.44%
2006 $6.84B 28.15%
2005 $5.34B -0.14%
2004 $5.34B 18.51%
2003 $4.51B 27.01%
2002 $3.55B 25.45%
2001 $2.83B 9.05%
2000 $2.60B 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$79.67B 52.31%
US
$97.93B 87.23%
US
$64.39B 23.10%
US
$77.52B 48.21%
CH
$66.40B 26.95%
US